(Q62111034)

English

Vaccine Therapy in Treating Patients With Multiple Myeloma Who Have Undergone Stem Cell Transplantation

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Phase I Trial of Post Transplant Immunization With Autologous Myeloma Idiotype-KLH/GM-CSF In Myeloma Patients Following Autologous or Allogeneic Marrow or Stem Cell Transplantation (English)

0 references

medical condition

multiple myeloma

0 references

country

United States of America

0 references

start time

March 1996

0 references

end time

December 2002

0 references

number of participants

40

0 references

research intervention

sargramostim

0 references

aldesleukin

0 references

clinical trial phase

phase I clinical trial

0 references

research site

University of Washington

0 references

research subject recruitment status

completed

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00002787

0 references

(Q62111034)

Vaccine Therapy in Treating Patients With Multiple Myeloma Who Have Undergone Stem Cell Transplantation

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)